| Literature DB >> 27442424 |
Jialing Lin1, Yang Peng2, Ping Xu1, Ting Zhang1, Chan Bai1, Dongxin Lin1, Qianting Ou1, Zhenjiang Yao1.
Abstract
OBJECTIVE: To determine the pooled prevalence and review the influencing factors of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in Chinese children.Entities:
Mesh:
Year: 2016 PMID: 27442424 PMCID: PMC4956239 DOI: 10.1371/journal.pone.0159728
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the selection process of the included studies.
Characteristics of selected studies.
| First author, publication year | Study period | Location | Setting | Age means, range | Presence of underlying condition | Sample size | MRSA prevalence (95% Confidence Interval) | Quality scores of studies | References |
|---|---|---|---|---|---|---|---|---|---|
| Shan Tan, 2015 | 2013–2014 | Sichuan | Hospital | -, 0-18y | 56 | 0.125 (0.038–0.212) | 6 | [ | |
| Jinjian Fu, 2015 | 2011 | Guangdong | Community | 8.7, 2.5-12y | Healthy | 1448 | 0.019 (0.012–0.026) | 6 | [ |
| Hongxiang Guo, 2013 | 2011–2012 | Henan | Hospital | 5.9d, 0-01m | Unclear | 1678 | 0.037 (0.028–0.046) | 7 | [ |
| Pakleung Ho, 2012 | 2009–2010 | Hong Kong | Community | 3.9, 2-5y | Healthy | 2211 | 0.013 (0.008–0.017) | 8 | [ |
| Jianjun Deng, 2012 | - | Sichuan | Community | -, 2-18y | Healthy | 2373 | 0.068 (0.058–0.078) | 7 | [ |
| Jianjun Deng, 2012 | - | Sichuan | Hospital | -, 0-16y | Respiratory infection | 315 | 0.010 (-0.001–0.002) | 7 | [ |
| Chihjung Chen, 2011 | 2005–2008 | Taiwan | Hospital | 25, 2-60m | Healthy | 6057 | 0.078 (0.071–0.085) | 8 | [ |
| Chingshen Tang, 2011 | 2005–2009 | Taiwan | Hospital | -, 0-18y | Atopic dermatitis | 188 | 0.191 (0.135–0.248) | 7 | [ |
| Juan Fan, 2011 | 2005 | Sichuan | Community | 4, 2-7y | Healthy | 801 | 0.011 (0.004–0.019) | 7 | [ |
| Yhuchering Huang, 2007 | 2005–2006 | Taiwan | Hospital | -, 2-5y | Healthy | 3046 | 0.073 (0.063–0.082) | 8 | [ |
| Poliang Lu, 2005 | 2001 | Taiwan | Community | -, 2-18y | Healthy | 987 | 0.033 (0.022–0.045) | 6 | [ |
| Yhuchering Huang, 2005 | 2001–2002 | Taiwan | Community | - | Healthy | 262 | 0.019 (0.003–0.036) | 8 | [ |
| KLE Hon, 2005 | 2004 | Hong Kong | Hospital | - | Atopic dermatitis | 55 | 0.018 (-0.017–0.053) | 6 | [ |
Fig 2Forest plot for MRSA prevalence and 95% CI for all selected studies.
(A) Pooled prevalence estimate of MRSA using random effect. (B) ES: effect size. (C) CI: confidence interval.
Prevalence estimates by subgroups.
| Subgroups | Number of studies | MRSA prevalence | 95% Confidence Interval | ||||
|---|---|---|---|---|---|---|---|
| Community | 6 | 0.027 | 0.012 | 0.043 | 0.001 | <0.001 | 95.3 |
| Hospital | 7 | 0.064 | 0.037 | 0.091 | <0.001 | 96.5 | |
| Healthy | 8 | 0.039 | 0.018 | 0.061 | <0.001 | <0.001 | 98.3 |
| Atopic dermatitis | 2 | 0.103 | -0.066 | 0.273 | 0.005 | 96.2 | |
| 1 | 0.125 | 0.138 | 0.212 | 0.233 | - | ||
| Respiratory infection | 1 | 0.010 | -0.001 | 0.020 | 0.082 | - | |
| Unclear | 1 | 0.037 | 0.028 | 0.046 | <0.001 | - | |
| Non-neonates | 12 | 0.046 | 0.027 | 0.064 | <0.001 | 0.001 | 97.6 |
| Neonates | 1 | 0.037 | 0.028 | 0.046 | <0.001 | - | |
| Mainland China | 6 | 0.033 | 0.013 | 0.052 | <0.001 | <0.001 | 95.3 |
| Taiwan | 5 | 0.067 | 0.041 | 0.094 | <0.001 | 95.8 | |
| Hong Kong | 2 | 0.013 | 0.007 | 0.017 | 0.761 | 0.0 | |
| 2001–2004 | 3 | 0.028 | 0.017 | 0.038 | 0.315 | 0.668 | 13.4 |
| 2005–2010 | 5 | 0.064 | 0.029 | 0.099 | <0.001 | 98.9 | |
| 2011–2014 | 3 | 0.033 | 0.013 | 0.053 | 0.001 | 85.7 | |
aThe significance of the overall effect is calculated by computing a z-score as the ratio of the overall effect to its standard error and comparing it with the standard normal distribution.
bTwo-sided z test was used to test difference of subgroups.
Influencing factors of MRSA nasal colonization in Chinese children reported in the selected studies.
| Influencing Factors, Odds ratio (95% confidence interval) | Jinjian Fu, 2015, [ | Hongxiang Guo, 2013, [ | Chihjung Chen, 2011, [ |
|---|---|---|---|
| Gender (male vs female) | 0.61 (0.26–1.40) | 1.17 (0.68–2.06) | 0.67 (0.55–0.82) |
| Age, y (2.5–6.7 vs 7–12) | 2.98 (1.31–6.96)* | - | 1.56 (1.21–2.00) |
| Attending day care centers after school (yes vs no) | 2.97 (1.28–6.76)* | - | 1.19 (0.89–1.57) |
| Using antibiotics in a year (yes vs no) | 1.71 (0.75–3.99) | 2.77 (1.45–5.05)* | 1.06 (0.87–1.28) |
| History of infection in a year (yes vs no) | 2.03 (0.80–4.77) | 2.31 (1.10–4.52)* | - |
| Having skin allergic diseases (yes vs no) | 1.37 (0.52–3.28) | - | - |
| History of receiving outpatient service in a year (yes or no) | 2.74 (0.96–7.50) | - | - |
| History of surgical operation in a year (yes or no) | 0.00 (0.00–7.04) | 2.35 (0.99–4.96) | - |
| Mode of production (normal childbirth vs Caesarean birth) | - | 1.18 (0.61–2.19) | - |
| History of hospitalization (yes vs no) | - | 1.21 (0.62–2.23) | - |
| Residing in northern Taiwan (yes vs no) | - | - | 1.41 (1.15–1.71) |
| Breast feeding (yes vs no) | - | - | 0.99 (0.73–1.37) |
| Sleeping with parents (yes vs no) | - | - | 1.11 (0.92–1.35) |
| Passive smoking (yes vs no) | - | - | 1.30 (1.02–1.63) |
| Pneumococcal vaccination (yes vs no) | - | - | 1.22 (1.01–1.48) |
| Flu vaccination (yes vs no) | - | - | 1.30 (0.96–1.73) |
| History of acute otitis media (yes vs no) | - | - | 1.12 (0.92–1.37) |
| Upper respiratory tract infection within 2 weeks (yes vs no) | - | - | 0.98 (0.66–1.41) |
| Premature birth (yes vs no) | - | - | 1.07 (0.71–1.56) |
| - | - | - | |
| Family members using antibiotics in a year (yes vs no) | 1.93 (0.84–4.70) | - | - |
| Family members’ history of skin infection in a year (yes vs no) | 0.73 (0.14–2.42) | - | - |
| Family members’ history of hospitalization in a year (yes vs no) | 2.01 (0.50–5.98) | 2.04 (0.76–4.65) | - |
| Family members are medical stuff (yes vs no) | 1.58 (0.39–4.69) | 2.35 (0.60–6.77) | - |
* Statistical significant odds ratios.
Fig 3Sensitivity analysis of MRSA prevalence.
(A) Results were computed by omitting each study in turn. (B) The two ends of the dotted lines represent the 95% CI.